Research Article | Open Access
Volume 4 | Issue 8 | Year 2017 | Article Id. IJMS-V4I8P101 | DOI : https://doi.org/10.14445/23939117/IJMS-V4I8P101

Juvenile Onset Still’s Disease Presenting as Pyrexia of Unknown Origin: A Case Report


Himanshu Juneja and Surekha Dabla

Citation :

Himanshu Juneja and Surekha Dabla, "Juvenile Onset Still’s Disease Presenting as Pyrexia of Unknown Origin: A Case Report," International Journal of Medical Science, vol. 4, no. 8, pp. 1-2, 2017. Crossref, https://doi.org/10.14445/23939117/IJMS-V4I8P101

Abstract

Juvenile onset still’s disease is a rare clinical entity with unknown etiology characterized by fever, evanescent rash, arthralgis and other systemic presentations. This report described a 15 year old male who presented with high grade fever, sore throat, rash, arthralgias, raised liver enzymes and hyperferritinemia. He was diagnosed to have Still’s Disease based on Yamuguchi criteria after the exclusion of other potential diagnoses. The patient started on methotrexate, etoricoxib and prednisolone and responded well to treatment.

Keywords

 Still’s disease, Yamuguchi criteria, Systemic onset Juvenile Idiopathic Arthritis.

References

[1] Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong   under juvenile idiopathic arthritis. Rheumatol 2005;44:1350-3.
[2] Luthi F, Zufferey P, Hofer MF, Adolescent-onset Still's disease: characteristics and outcome in comparison with adult-onset Still's disease.Clin.Exp. Rheumatol. 2002; 20: 427–30.
[3] Hinks, A; Cobb, J; Prahalad S; Sudman, Marc; Glass, David; Langefeld, Carl; Thomson, Wendy; Thompson, Susan et al. Dense genotyping of immune loci using Immuno Chip identifies 14 new susceptibility loci for juvenile idiopathic arthritis". Nature Genetics 2013; 45:664–9.
[4] Yamaguchi M, Ohta A, Tsunematsu T. Preliminary criteria for classification of adult Still’s disease. J. Rheumatol. 1992; 19:424–30.
[5] De Witt, Morgan; Kimura, Yukiko; Beukelman, Timothy; Nigrovic, Peter A. Onel K et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care & Research 2012; 64:1001–10.